Citation Impact
Citing Papers
2017 Standout
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Carotenoids: biochemistry, pharmacology and treatment
2016 Standout
Rodent-borne diseases and their risks for public health
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Hyperoxia, reactive oxygen species, and hyperventilation: oxygen sensitivity of brain stem neurons
2004 StandoutNobel
Exercise with incorporated expiratory manoeuvres was as effective as breathing techniques for airway clearance in children with cystic fibrosis: a randomised crossover trial
2012
Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation
2001
Inhaled P2Y2 receptor agonists as a treatment for patients with Cystic Fibrosis lung disease
2002
5-HT2 receptors modulate excitatory neurotransmission to cardiac vagal neurons within the nucleus ambiguus evoked during and after hypoxia
2009 StandoutNobel
Cystic fibrosis
2016 Standout
Chronic Venous Disease
2006 Standout
A Comparison of Brain Gene Expression Levels in Domesticated and Wild Animals
2012 StandoutNobel
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
2014 Standout
Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence
1993 Standout
Pulmonary fibrosis: pathogenesis, etiology and regulation
2009 Standout
β-Carotene breakdown products may impair mitochondrial functions — potential side effects of high-dose β-carotene supplementation
2005
Genotype and Phenotype in Cystic Fibrosis
2000
Antithrombotic Therapy for VTE Disease
2016 Standout
A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
1988 Standout
The neuropeptide/mast cell secretagogue substance P is expressed in cutaneous melanocytic lesions
1998
Hibiscus sabdariffa L. – A phytochemical and pharmacological review
2014 Standout
Effects of oral administration of different doses of purified micronized flavonoid fraction on microvascular reactivity after ischaemia/reperfusion in the hamster cheek pouch
1997
Parietal and Occipital Lobe Epilepsy: A Review
1993
Antithrombotic Therapy for VTE Disease
2012 Standout
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
Endothelial Activation Response to Oral Micronised Flavonoid Therapy in Patients with Chronic Venous Disease – a Prospective Study
1999
The biochemistry and medical significance of the flavonoids
2002 Standout
Medullary Serotonergic Network Deficiency in the Sudden Infant Death Syndrome: Review of a 15-Year Study of a Single Dataset
2001
N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology
2007 Standout
Genotype–phenotype correlation in cystic fibrosis: The role of modifier genes
2002
Intestinal mucosal barrier function in health and disease
2009 Standout
Clinical Efficacy of Micronized Purified Flavonoid Fraction: An Overview
1999
P2Y2 nucleotide receptor up-regulation in submandibular gland cells from the NOD.B10 mouse model of Sjögren's syndrome
2004
Cystic fibrosis
1998
Cystic fibrosis genetics: from molecular understanding to clinical application
2014 Standout
A review of MRI findings in schizophrenia
2001 Standout
Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function
2003
Mutations in the human Delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis
2000
Acetaminophen-induced liver damage in mice: Effects of some medicinal plants on the oxidative defense system
2007
Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients
2003
Animal models of chronic pain: Their possible validation from human experience with posterior rhizotomy and congenital analgesia (Part I of the Second John J. Bonica Lecture)
1981
Lymphocytic choriomeningitis virus: An emerging obstetric pathogen?
2006
Antiinflammatory Therapies for Cystic Fibrosis: Past, Present, and Future
2005
Micronised Purified Flavonoid Fraction
2003
Brainstem Serotonergic Deficiency in Sudden Infant Death Syndrome
2010
Plasma VEGF as a Marker of Therapy in Patients with Chronic Venous Disease Treated with Oral Micronised Flavonoid Fraction – a Pilot Study
1999
<p>Reactive Oxygen Species: Drivers of Physiological and Pathological Processes</p>
2020 Standout
Update on Key Emerging Challenges in Cystic Fibrosis
2014 Standout
Intracerebral myiasis from Hypoderma bovis larva in a child
1989
The importance of glutathione in human disease
2003 Standout
Antioxidant micronutrients for lung disease in cystic fibrosis
2010
Photoplethysmography and its application in clinical physiological measurement
2007 Standout
Changes in Cerebrospinal Fluid Monoamine Metabolites, Tryptophan, and γ-Aminobutyric Acid during the 1st Year of Life in Normal Infants
1999
Chemistry and pharmacology of the citrus bioflavonoid hesperidin
2001 Standout
Clinical Benefits of Daflon 500 mg in the Most Severe Stages of Chronic Venous Insufficiency
2001
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Infant sleeping position and the sudden infant death syndrome: systematic review of observational studies and historical review of recommendations from 1940 to 2002
2005
Developmental neurotransmitter pathology in the brainstem of sudden infant death syndrome: a review and sleep position
2002
Clinical Features Associated with a Delayed Diagnosis of Cystic Fibrosis
2000
Pulmonary Function and Clinical Observations in Men With Congenital Bilateral Absence of the Vas Deferens
1996
Airway Inflammation and Infection in Congenital Bilateral Absence of the Vas Deferens
2003
Myiasis of Humans and Domestic Animals
1995 Standout
The Role of Selenium in Inflammation and Immunity: From Molecular Mechanisms to Therapeutic Opportunities
2011 Standout
Therapeutic Potential of Flavonoids in Pain and Inflammation: Mechanisms of Action, Pre-Clinical and Clinical Data, and Pharmaceutical Development
2020
SIDS and Other Sleep-Related Infant Deaths: Expansion of Recommendations for a Safe Infant Sleeping Environment
2011 Standout
The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum
2011 Standout
Veno-active drugs in the management of chronic venous disease. An international consensus statement: current medical position, prospective views and final resolution.
2005
N -Acetylaspartate in neuropsychiatric disorders
1995
Phlebotonics for venous insufficiency
2005
Phlebotonics for venous insufficiency
2016
Update on Uses and Properties of Citrus Flavonoids: New Findings in Anticancer, Cardiovascular, and Anti-inflammatory Activity
2008 Standout
Role of CFTR in Airway Disease
1999
Inflammatory Bowel Disease
2010 Standout
Management of chronic venous disorders of the lower limbs - guidelines according to scientific evidence.
2008
Neuropathology of sudden infant death (syndrome): literature review and evidence of a probable apoptotic degenerative cause
2002
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
2001 Standout
Flavonoid treatment reduces glycation and lipid peroxidation in experimental diabetic rats
1994
Secondary chronic venous disorders
2007
The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Management and Treatment of Meibomian Gland Dysfunction
2011 Standout
Pathophysiology of Sleep Apnea
2010 Standout
Flavonoids as Potential Anti-Inflammatory Molecules: A Review
2022 Standout
Investigation of Chronic Venous Insufficiency
2000 Standout
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Receptors for Purines and Pyrimidines
2012 Standout
Inefficient Transcription of the Myelin Basic Protein Gene Possibly Causes Hypomyelination in Myelin‐Deficient Mutant Mice
1987
The Brainstem and Serotonin in the Sudden Infant Death Syndrome
2009
Vascular Calcification
2006 Standout
Neuropeptide Localization in the ‘Migraine Generator’ Region of the Human Brainstem
2001
Lung Infections Associated with Cystic Fibrosis
2002 Standout
Vascular Calcification
2004 Standout
Antioxidant and Anti-Inflammatory Properties of the Citrus Flavonoids Hesperidin and Hesperetin: An Updated Review of their Molecular Mechanisms and Experimental Models
2014 Standout
From Skin Disorders to Venous Leg Ulcers: Pathophysiology and Efficacy of Daflon 500 mg in Ulcer Healing
2003
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Efficacy of Daflon 500 mg in Venous Leg Ulcer Healing: A Double-Blind, Randomized, Controlled Versus Placebo Trial in 107 Patients
1997
Developing and Evaluating Complex Interventions: New Guidance
2006 Standout
Works of R Gilly being referenced
[Transplacental infection by lymphocytic choriomeningitis virus. Results of a retrospective serological study in France (author's transl)].
1978
[Spondylo-vertebral and spondylo-thoracic dysostosis. Clinical, radiological and genetic study, apropos of 7 observations].
1978
Absence of Adrenergic Neurons in Nucleus Tractus Solitarius in Sudden Infant Death Syndrome
1993
Studies of Neuroregulators in the Brain Stem of SIDS
1994
Regional distribution of substance P binding sites in the brainstem of the human newborn
1995
Lipid Peroxidation and Antioxidant Defenses in Cystic Fibrosis Patients
1999
Catecholamine Synthesizing Enzyme Activity in Brainstem Areas from Victims of Sudden Infant Death Syndrome
1987
Diagnostic Criteria for Cystic Fibrosis in Men with Congenital Absence of the Vas Deferens
1995
Biochemical assessment of the nutritional status of cystic fibrosis patients treated with pancreatic enzyme extracts
1998
[Cystic fibrosis in adults].
1996
Intracerebral myiasis in a child
1980
Sudden infant death syndrome: Organic acid profiles in cerebrospinal fluid from 47 children and the occurrence ofN‐acetylaspartic acid
1990
Prevention of Recurrent Febrile Convulsions - A Randomized Therapeutic Assay: Sodium Valproate, Phenobarbital and Placebo1
1984
[Visual seizures and benign epilepsy in children with paroxysmal occipital discharges].
1987
[Immunohistochemical absence of adrenergic neurons in the dorsal part of the solitary tract nucleus in sudden infant death].
1989
Evaluation of a New Venoactive Micronized Flavonoid Fraction (S 5682) in Symptomatic Disturbances of the Venolymphatic Circulation of the Lower Limb: A Double-Blind, Placebo-Controlled Study
1994
A critical comparison of the history of sudden-death infants and infants hospitalised for near-miss for SIDS
1984
Clinical evaluation of a venotropic drug in man. Example of Daflon 500 mg.
1988
Flow-volume curves in children in health and disease.
1986
[N-acetylaspartic aciduria. Clinical, biological and physiopathological study].
1991
Mutation analysis in 600 French cystic fibrosis patients.
1994
[CONGENITAL INDIFFERENCE TO PAIN. FAMILIAL CASE; CLINICAL AND BIOLOGICAL PECULIARITIES].
1996
[Activities of enzymes synthesizing catecholamines in areas of the brain stem in sudden infant death].
1980